This site is for customers in Asia.
Customers in China & other regions, please go to Global page.
HOME > Product search results
Searched by
Product（45）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
1
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M703-1 |
T-Select I-Ad OVA323-339 Tetramer-PE |
|
|||
|
OVA | PE | I-Ad | 20 tests |
0 (Contact us) |
|
| ISQAVHAAHAEINEAGR | 323-339 | ４°C | ||||
|
|
TS-M722-1 |
T-Select I-Ab mouse 2W1S Tetramer-PE |
|
|||
|
|
Others | PE | I-Ab | 20 tests | 1-9 | |
| EAWGALANWAVDSA | 52-68 | ４°C | ||||
|
|
TS-M716-2 |
T-Select I-Ab Influenza NP311-325 Tetramer-APC |
|
|||
|
|
virus Influenza |
APC | I-Ab | 20 tests |
0 (Contact us) |
|
| QVYSLIRPNENPAHK | 311-325 | ４°C | ||||
|
|
TS-M720-1 |
T-Select I-Ad human CLIP103-117 Tetramer-PE |
|
|||
|
|
negative | PE | I-Ad | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M715-1 |
T-Select I-Ab human CLIP103-117 Tetramer-PE |
|
|||
|
|
negative | PE | I-Ab | 20 tests | 10 or more | |
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M816-1 |
HLA-DRB1*15:01 human CLIP103-117 Tetramer-PVSKMRMATPLLMQA-PE |
|
|||
|
|
negative | PE | DRB1*15:01 | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M720-2 |
T-Select I-Ad human CLIP103-117 Tetramer-APC |
|
|||
|
|
negative | APC | I-Ad | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M817-1 |
HLA-DRB1*15:02 human CLIP103-117 Tetramer-PVSKMRMATPLLMQA-PE |
|
|||
|
|
negative | PE | DRB1*15:02 | 20 tests | 1-9 | |
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M703-2 |
T-Select I-Ad OVA323-339 Tetramer-APC |
|
|||
|
|
OVA | APC | I-Ad | 20 tests |
0 (Contact us) |
|
| ISQAVHAAHAEINEAGR | 323-339 | ４°C | ||||
|
|
TS-M716-1 |
T-Select I-Ab Influenza NP311-325 Tetramer-PE |
|
|||
|
|
virus Influenza |
PE | I-Ab | 20 tests | 1-9 | |
| QVYSLIRPNENPAHK | 311-325 | ４°C | ||||
|
|
TS-M812-1 |
HLA-DRB1*11:01 TT p2829-844 Tetramer-MQYIKANSKFIGITEL-PE |
|
|||
|
|
bacteria | PE | DRB1*11:01 | 20 tests |
0 (Contact us) |
|
| MQYIKANSKFIGITEL | 829-844 | ４°C | ||||
|
|
TS-M722-2 |
T-Select I-Ab mouse 2W1S Tetramer-APC |
|
|||
|
|
Others | APC | I-Ab | 20 tests |
0 (Contact us) |
|
| EAWGALANWAVDSA | 52-68 | ４°C | ||||
|
|
TS-M812-2 |
HLA-DRB1*11:01 TT p2829-844 Tetramer-MQYIKANSKFIGITEL-APC |
|
|||
|
|
bacteria | APC | DRB1*11:01 | 20 tests |
0 (Contact us) |
|
| MQYIKANSKFIGITEL | 829-844 | ４°C | ||||
|
|
TS-M715-2 |
T-Select I-Ab human CLIP103-117 Tetramer-APC |
|
|||
|
|
negative | APC | I-Ab | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M817-2 |
HLA-DRB1*15:02 human CLIP103-117 Tetramer-PVSKMRMATPLLMQA-APC |
|
|||
|
|
negative | APC | DRB1*15:02 | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M816-2 |
HLA-DRB1*15:01 human CLIP103-117 Tetramer-PVSKMRMATPLLMQA-APC |
|
|||
|
|
negative | APC | DRB1*15:01 | 20 tests |
0 (Contact us) |
|
| PVSKMRMATPLLMQA | 103-117 | ４°C | ||||
|
|
TS-M160-1 |
HLA-A*02:01 EBV LMP2 Tetramer-GLGTLGAAL-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLGTLGAAL | 293-301 | ４°C | ||||
|
|
TS-M151-1 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-PE
|
|
|||
|
|
negative | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALAAAAAAV | ４°C | |||||
|
|
TS-M154-2 |
HLA-A*24:02 EBV LMP2 Tetramer-TYGPVFMCL-APC
|
|
|||
|
|
virus | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYGPVFMCL | 419-427 | ４°C | ||||
|
|
TS-M156-1 |
HLA-A*02:01 EBV LMP2 L6I Tetramer-CLGGLITMV-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CLGGLITMV | 426-434 | ４°C | ||||
|
|
TS-M159-2 |
HLA-A*02:01 EBV LMP2 Tetramer-QLSPLLGAV-APC
|
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLSPLLGAV | 264-272 | ４°C | ||||
|
|
TS-M157-2 |
HLA-A*02:01 EBV LMP2 Y3C Tetramer-FLCALALLL-APC
|
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLCALALLL | 356-364 | ４°C | ||||
|
|
TS-M154-1 |
HLA-A*24:02 EBV LMP2 Tetramer-TYGPVFMCL-PE
|
|
|||
|
|
virus | PE | A*24:02 | 50 tests | 1-9 | |
| TYGPVFMCL | 419-427 | ４°C | ||||
|
|
TS-M001-2 |
HLA-A*24:02 EBV LMP2 Tetramer-IYVLVMLVL-APC
|
|
|||
|
|
virus | APC | A*24:02 | 50 tests | 1-9 | |
| IYVLVMLVL | 222-230 | ４°C | ||||
|
|
TS-M155-1 |
HLA-A*02:01 EBV LMP2 C1S Tetramer-SLGGLLTMV-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLGGLLTMV | 426-434 | ４°C | ||||
|
|
TS-M155-2 |
HLA-A*02:01 EBV LMP2 C1S Tetramer-SLGGLLTMV-APC
|
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLGGLLTMV | 426-434 | ４°C | ||||
|
|
TS-M164-2 |
HLA-A*24:02 HHV-6B U54 Tetramer-PFHCSFHTI-APC
|
|
|||
|
|
virus | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| PFHCSFHTI | 267-275 | ４°C | ||||
|
|
TS-M153-1 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-PE
|
|
|||
|
|
negative | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| AYAAAAAAL | ４°C | |||||
|
|
TS-M161-1 |
HLA-A*02:01 EBV LMP2 I6M Tetramer-TVCGGMMFL-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TVCGGMMFL | 243-251 | ４°C | ||||
|
|
TS-M161-2 |
HLA-A*02:01 EBV LMP2 I6M Tetramer-TVCGGMMFL-APC
|
|
|||
|
|
virus EBV |
APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TVCGGMMFL | 243-251 | ４°C | ||||
|
|
TS-M160-2 |
HLA-A*02:01 EBV LMP2 Tetramer-GLGTLGAAL-APC
|
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLGTLGAAL | 293-301 | ４°C | ||||
|
|
TS-M156-2 |
HLA-A*02:01 EBV LMP2 L6I Tetramer-CLGGLITMV-APC
|
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CLGGLITMV | 426-434 | ４°C | ||||
|
|
TS-M164-1 |
HLA-A*24:02 HHV-6B U54 Tetramer-PFHCSFHTI-PE
|
|
|||
|
|
virus | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| PFHCSFHTI | 267-275 | ４°C | ||||
|
|
TS-M157-1 |
HLA-A*02:01 EBV LMP2 Y3C Tetramer-FLCALALLL-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLCALALLL | 356-364 | ４°C | ||||
|
|
TS-M159-1 |
HLA-A*02:01 EBV LMP2 Tetramer-QLSPLLGAV-PE
|
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLSPLLGAV | 264-272 | ４°C | ||||
|
|
TS-M151-P |
HLA-A*02:01 Control Peptide |
|
|||
|
|
negative | Peptide | A*02:01 | 100 µL (10 mg/ mL) | 1-9 | |
| ALAAAAAAV | －２０°C | |||||
|
|
TS-M153-P |
HLA-A*24:02 Control Peptide |
|
|||
|
|
negative | Peptide | A*24:02 | 100 µL (10 mg/ mL) |
0 (Contact us) |
|
| AYAAAAAAL | －２０°C | |||||
|
|
TS-M153-2 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-APC
|
|
|||
|
|
negative | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| AYAAAAAAL | ４°C | |||||
|
|
TS-M151-2 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-APC
|
|
|||
|
|
negative | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALAAAAAAV | ４°C | |||||
|
|
TS-M151-3 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-FITC
|
|
|||
|
|
negative | FITC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALAAAAAAV | ４°C | |||||
|
|
TS-M153-3 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-FITC
|
|
|||
|
|
negative | FITC | A*24:02 | 50 tests |
0 (Contact us) |
|
| AYAAAAAAL | ４°C | |||||
|
|
TS-M152-P |
HLA-A*11:01 Control Peptide |
|
|||
|
|
negative | Peptide | A*11:01 | 100 µL (10 mg/ mL) |
0 (Contact us) |
|
| ATAAAAAAK | －２０°C | |||||
|
|
TS-M152-3 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-FITC
|
|
|||
|
|
negative | FITC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
|
|
TS-M152-1 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE
|
|
|||
|
|
negative | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
|
|
TS-M152-2 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC
|
|
|||
|
|
negative | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
1
- The availability is based on the information in Japan at 00:05, Aug 18, 2018 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.